01—History
Shares Outstanding History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- 43.6M
02—Ledger
Shares Outstanding, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | 43.6M | −2.7% | 10-K | |
| FY2024 | 44.8M | −4.7% | 10-K | |
| FY2023 | 47.0M | +2.2% | 10-K | |
| FY2022 | 46.0M | +2.0% | 10-K | |
| FY2021 | 45.1M | +1.3% | 10-K | |
| FY2020 | 44.5M | +1.4% | 10-K | |
| FY2019 | 43.9M | +0.7% | 10-K | |
| FY2018 | 43.6M | +0.8% | 10-K | |
| FY2017 | 43.2M | +0.6% | 10-K | |
| FY2016 | 43.0M | −6.1% | 10-K | |
| FY2015 | 45.8M | −2.9% | 10-K | |
| FY2014 | 47.1M | −6.5% | 10-K | |
| FY2013 | 50.4M | +0.4% | 10-K | |
| FY2012 | 50.2M | −6.4% | 10-K | |
| FY2011 | 53.6M | −6.9% | 10-K | |
| FY2010 | 57.6M | +6.2% | 10-K | |
| FY2009 | 54.2M | — | 10-K |
03—Questions
What is shares outstanding?
Shares outstanding is the total number of common shares currently held by all shareholders, including restricted shares.
What is United Therapeutics's current shares outstanding?
United Therapeutics (UTHR) annual shares outstanding for 2025 was 43.6M, a 2.65% decline from 2024. United Therapeutics shares outstanding for the quarter ending September 30, 2026 was 42.4M.
What was United Therapeutics's shares outstanding in 2024?
United Therapeutics annual shares outstanding for 2024 was 44.8M, a 4.70% decline from 2023.
What was United Therapeutics's shares outstanding in 2023?
United Therapeutics annual shares outstanding for 2023 was 47.0M, a 2.19% increase from 2022.
What is United Therapeutics's 5-year shares outstanding CAGR?
United Therapeutics shares outstanding grew at a compound annual growth rate (CAGR) of 0.39% from FY2020 to FY2025, going from 44.5M to 43.6M over 5 years.
- Company
- United Therapeutics
- Ticker
- UTHR
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations